Equities

Avalon Globocare Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ALBT:NAQ

Avalon Globocare Corp

Actions
Real EstateReal Estate Investment and Services
  • Price (USD)0.8493
  • Today's Change0.021 / 2.57%
  • Shares traded203.78k
  • 1 Year change-76.01%
  • Beta-0.0801
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.

  • Revenue in USD (TTM)1.40m
  • Net income in USD-18.76m
  • Incorporated2014
  • Employees5.00
  • Location
    Avalon Globocare Corp4400 ROUTE 9, SUITE 3100FREEHOLD 07728United StatesUSA
  • Phone+1 (732) 780-4400
  • Fax+1 (732) 780-5600
  • Websitehttps://www.avalon-globocare.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ALBT:NAQ since
announced
Transaction
value
YOOV Group Holding LtdDeal completed10 Mar 202510 Mar 2025Deal completed-88.25%--
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Agape ATP Corp1.48m-2.71m2.51m16.00--0.1099--1.69-14.97-14.972.6122.830.104713.9960.1492,806.88-19.46-34.76-21.27-44.4452.6869.19-185.74-92.8616.18--0.0056---7.57---17.53------
INVO Fertility Inc6.94m-27.13m2.63m28.00------0.3781-602.89-644.6750.028.630.387419.5026.14247,996.40-149.96-63.14-299.48-98.9639.1760.46-387.11-276.300.1022-10.360.2530--116.2534.57-16.33--9.88--
Autonomix Medical Inc0.00-16.69m2.67m8.00--0.3716-----5.08-5.080.001.040.00----0.00-250.94---316.15--------------0.00------26.03------
Work Medical Technology Group Ltd10.74m-3.71m2.81m229.00--0.0002--0.2617-2,871.58-2,871.587,811.598,868.19------46,903.67--------26.89---35.42--0.9802-8.870.4505---15.18---3,217.31------
ENvue Medical Inc2.69m-5.21m2.95m15.00--0.0645--1.10-83.93-83.937.4642.000.09090.83646.45179,000.00-25.01-97.63-32.90-149.1830.0253.04-275.12-397.830.6675--0.0669--12.0537.000.1617------
Fuse Medical Inc18.40m3.63m2.96m31.001.11--0.80140.16060.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Catheter Precision Inc730.00k-22.19m3.17m22.00--0.4614--4.34-37.38-37.380.93714.120.0281.646.3533,181.82-66.93-128.03-78.29-160.1292.60-242.70-2,393.84-15,268.880.4569-66.840.0449---4.98-19.8969.45---24.21--
Encision Inc6.30m-380.94k3.19m22.00--1.71--0.5061-0.0284-0.02840.50570.11051.662.277.98286,353.60-10.05-3.17-14.19-4.4052.6451.47-6.05-2.010.9127-5.690.1094---0.464-3.0968.17--8.09--
Avalon Globocare Corp1.40m-18.76m3.52m5.00------2.52-9.75-9.750.6074-1.100.0974--16.92279,216.00-131.94-76.04-1,379.37-114.3725.7023.19-1,355.20-888.890.1477-4.072.69--6.19-2.9252.69------
Profusa Inc0.00-39.09m3.62m0.00---------278.73-278.730.00-61.050.00-------599.88-----------------14.56---------849.77------
Vycor Medical Inc1.90m-338.88k3.67m7.00------1.93-0.0103-0.01030.0548-0.12061.891.576.73271,678.60-1.44-36.90----85.3589.43-0.7625-26.120.10280.8609----8.812.67-11.32---40.90--
Reflect Scientific Inc1.72m-29.42k4.10m7.00--1.9721.952.38-0.0004-0.00040.02010.02430.68260.84298.78245,945.70-1.1711.10-1.3213.2158.4762.48-1.7110.009.46--0.00---47.09-6.99-613.46------
Nuwellis Inc8.17m-16.56m4.14m38.00--0.7719--0.5070-107.66-107.6626.642.871.111.656.71214,947.40-225.22-87.78-390.32-108.5359.0757.73-202.83-195.831.42-1.050.00---1.409.6653.05---34.30--
bioAffinity Technologies Inc6.78m-14.74m4.47m57.00--0.3867--0.6592-20.74-20.749.342.570.7489161.377.97118,890.20-162.88---222.52--27.86---217.50--3.64-2.690.0332--269.68---13.89------
Axim Biotechnologies Inc92.90k-4.14m4.59m6.00------49.46-0.0163-0.01630.0003-0.03240.0233----15,483.33-103.73-154.34---390.7316.94---4,451.97-36,362.71---3.14----345.05-27.38-29.10------
Dalrada Financial Corp18.37m-23.89m4.69m0.00------0.2551-0.2172-0.21720.1626-0.13030.90894.865.34---118.42-100.15-1,575.08-1,511.4525.5728.94-130.29-92.980.2685-6.36----2.3276.7114.86--15.56--
Data as of Feb 12 2026. Currency figures normalised to Avalon Globocare Corp's reporting currency: US Dollar USD

Institutional shareholders

2.00%Per cent of shares held by top holders
HolderShares% Held
UBS Securities LLCas of 31 Dec 202524.40k0.54%
Geode Capital Management LLCas of 30 Sep 202522.08k0.48%
Procyon Advisors LLCas of 31 Dec 202518.60k0.41%
Vanguard Fiduciary Trust Co.as of 31 Dec 202518.39k0.40%
The Vanguard Group, Inc.as of 31 Dec 20256.99k0.15%
Tower Research Capital LLCas of 30 Sep 2025453.000.01%
Citigroup Global Markets, Inc. (Investment Management)as of 30 Sep 2025131.000.00%
BofA Securities, Inc.as of 30 Sep 2025100.000.00%
Bank of America, NA (Private Banking)as of 30 Sep 202528.000.00%
SBI Securities Co., Ltd.as of 31 Dec 20257.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.